FDA Committee Recommends Allowing Vaccine for Ages 5-11

A U.S. Food and Drug Administration advisory committee has recommended authorization of Pfizer-BioNTech pediatric vaccine for ages 5 to 11.  

The next steps toward approval are the FDA authorization, discussion and recommendation by the Advisory Committee on Immunization Practices, scheduled to meet Nov. 2, and a final decision by the CDC director. The process could mean vaccination could begin in early November.  

Topics: Vaccine

Written by Argentum

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:


Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.